Human brain monoamine oxidase: multiple forms and selective inhibitors.
about
Rasagiline: an anti-Parkinson drug with neuroprotective activity.Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illnessChemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UKInhibition of monoamine oxidase by (E)-styrylisatin analoguesDual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseElectroacupuncture Restores 5-HT System Deficit in Chronic Mild Stress-Induced Depressed Rats.The role of rasagiline in the treatment of Parkinson's disease.The modern management of Parkinson's disease.New look at monoamine oxidase inhibitors. The new biochemical backgroundA comparison of methodologies for the study of functional transmitter neurochemistry in human brain.Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor.Studies of monoamine oxidases: properties of the enzyme in bovine and rabbit brain mitochondria.3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors.
P2860
Q35006961-5DFD63B2-E8F9-46A2-8676-C1AA96399A05Q35566604-E2ABA976-5ED0-4174-8332-D0227F7D08C5Q36250876-A3DBE79E-5323-45FE-8DCA-CEDC6885AA7BQ36842508-3D5BECA4-3FB7-452F-AA22-355355B69978Q37218632-A60359B6-98C4-4C62-8366-1630475E041CQ37358676-C2678264-266B-4868-8CA0-5CC0D68218A1Q37479989-4D4EC6A3-C282-4508-9E68-3B829A388780Q37762167-8687BD35-F6DD-43ED-B180-B88B935B5C6EQ37809006-E012D6F5-171E-4F3E-93BA-88B8FDEB8C70Q39419788-C158BFFA-8F89-4349-9378-4E5798B41D8DQ39467472-13840894-3414-4F18-B96A-23A9A3844C13Q40006784-4989C5B8-F49E-4141-8474-8FB218FF7E5EQ40021206-791A9169-A76E-4619-8545-E606097E2D0EQ43083902-6461989E-7B82-457A-919A-8FFE1D01EC28Q48099692-FDE775E2-ABCB-447E-87E9-4D3A357E7A11Q48352927-B8FDE26D-F104-4C50-B3C5-82846259D4ABQ48491402-720DD7CA-1543-4F5C-9C23-3883412CB6E3Q48560717-ED92F934-CA9B-4F0E-8277-DF103418A6E7Q49496403-7FEA0AFF-C5CD-46D2-9149-F8259291EC49
P2860
Human brain monoamine oxidase: multiple forms and selective inhibitors.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
1972年论文
@zh
1972年论文
@zh-cn
name
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@en
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@nl
type
label
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@en
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@nl
prefLabel
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@en
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Human brain monoamine oxidase: multiple forms and selective inhibitors.
@en
P2093
Bevan Jones AB
Collins GG
Nicholson WJ
P2860
P2888
P304
P356
10.1038/236225B0
P407
P577
1972-03-01T00:00:00Z
P6179
1041609035